<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Vifor Pharma AG 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=41177></link><description><![CDATA[Vifor Pharma AG 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 16 Apr 2026 13:57:34 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2022/10/12_31017998_20221012171339_5829948781.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Approval of extension of exemptions from SIX disclosure and publicity obligations]]></title><link>https://www.newswire.co.kr/newsRead.php?no=953866</link><description><![CDATA[ST. GALLEN, Switzerland--(Business Wire/Korea Newswire)--Regulatory News:  AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an extension of the various exemptions from certain disclosure and publicity obligations granted by SER to Vifor Pharma AG previously (see Vifor Pharma AG's a...]]></description><pubDate>Thu, 20 Oct 2022 16:25:00 +0900</pubDate></item><item><title><![CDATA[Approval of delisting of Vifor Pharma AG&#039;s registered shares]]></title><link>https://www.newswire.co.kr/newsRead.php?no=953225</link><description><![CDATA[ST. GALLEN, SWITZERLAND--(Business Wire/Korea Newswire)--Regulatory News:  AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  Vifor Pharma AG (SWX:VIFN) (Vifor) announced today that Vifor has received approval for the delisting of the totality of Vifor's registered shares.  On August 18, Vifor applied to SIX Exchange Regulation AG (SER) for the delisting of the totality of its registered shares. With its dec...]]></description><pubDate>Wed, 12 Oct 2022 17:20:00 +0900</pubDate></item><item><title><![CDATA[Finalization of Vifor Pharma acquisition]]></title><link>https://www.newswire.co.kr/newsRead.php?no=948965</link><description><![CDATA[MELBOURNE, Australia & ST. GALLEN, Switzerland--(Business Wire/Korea Newswire)--Regulatory News:  AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR  CSL Limited (ASX: CSL; USOTC:CSLLY) is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG (Vifor) announced on 14 December 2021.  CSL has set the settlement date of the public tender offer for Vifor for 9 August 2022. If ...]]></description><pubDate>Tue, 02 Aug 2022 17:05:00 +0900</pubDate></item></channel></rss>